SlideShare a Scribd company logo
2
Most read
8
Most read
9
Most read
UNIT IV
COMPLEXATION AND PROTEIN
BINDING
By: Ms. Swati Gaikwad
Assistant Professor
Nagpur Pharmacy College ,wanadongri.Nagpur
METHODS OF ANALYSIS
In the study and application of complex compounds, determination of stoichiometric ratio and stability
constant is very important.
1. The stoichiometric ratio of ligand-to-metal or donor-to-acceptor.
2. Stability constant of the complex.
The general methods and procedure for obtaining these quantity is as follows.
1. Method of continuous variation
2. pH titration method
3. Distribution method
4. Solubility method
1. Method of continuous variation
• For the measurement of complexation, additive properties such as spectrophotometric extinction
coefficient (absorbance), dielectric constant, refractive index etc are used.
• If solutions of two species A and B are are mixed & they have no interaction or complexation, then
value of property is additive and linear relationship is observed.
• If Complexation occurs, the value of additive property will pass through maximum or minimum.
• As shown in the figure, dielectric constant is plotted against mole fraction, and a dashed line shows
that no complexation occurs and there is a linear relationship,
• whereas the break or change in slope in the upper curve indicates formation of complex.
• Mole fraction corresponding to the change in slope i.e. 0.5 indicates stoichiometric ratio or 1:1
complex type.
• When spectrophotometric absorbance is used, observed values at various mole fractions is subtracted from
the corresponding values that would have been expected from results of no complex.
• The difference D is then plotted against the mole fraction, and from the curve fig ,molar ratio of complex is
obtained.
• And stability constant can be determined by means of a calculation involving concentration and absorbance
difference.
Property such as absorbance is proportional to the concentration of complex M An, hence molar ratio of
ligand A and metal M and stability constant can be determined
The equation for complexation can be written as
And the stability constant can be written as
Or in logarithmic form,
Where, k = equilibrium stability constant
[M] = concentration of metal ion uncomplexed
[A] = concentration of ligand (A) uncomplexed
n = Number of moles of ligand combined with one mole of metal ion
[MAn] = concentration of complex
2. pH titration method
• Whenever complexation is accompanied by the change in pH, pH titration method can be used.
• It is the most reliable method to be used.
• For example, complexation between the cupric ion and Glycine, when Glycine is added to the solution
containing the cupric ions, it reacts with cupric ions and release two proton, which decreases the pH
of the solution.
• The potentiometric titrations are carried out and titration curves are plotted between the pH and
equivalents of base added to the solution.
• The figure shows that curve obtained with Glycine alone is well above and there is not much change in
pH, while the curve for metal Glycine mixture indicates pH is decreased means that the
complexation is occurring.
• The horizontal distance between the two curves gives the amount of alkali consumed in the
reaction, and this quantity is exactly equal to the concentration of ligand bound at that pH.
Titration curves of cupric-glycine complex, and glycine. the difference in pH for a given
quantity of NaoH indicates formation of complex
Complexation 3
Complexation 3
Solubility method
 This method exploits the change in solubility profile as a criterion to analyze the
complexation.
 Whenever the complexation is produced between the two components, there is inhibition
or enhancement in the solubility of one of the component.
 According to the solubility method, in different well stoppered containers solution of
complexing agent is placed with excess quantities of drug.
 These containers agitated in constant temperature bath until equilibrium is attained and
supernatant liquid are removed and analyzed.
 For example, complexation between p-amino benzoic acid and caffeine.
 It is shown in the figure 5.16; the point A crossing the vertical axis indicates the
solubility of drug in water.
 As there is addition of caffeine, there is increase in the solubility of PABA linearly due
to complexation.
 As it reaches point B, there is saturation in the solution and it cannot solubilize drug
anymore.
 Further, increase in caffeine concentration, there is formation of complex and
precipitate.
 At point C all excess PABA passed into the solution and has been converted to
complex.
 But some uncomplexed molecules of PABA combine further with caffeine and form
higher complex such as PABA 2- caffeine.
PROTEIN BINDING
Proteins in the body can bind to the drug and can influence drug action in number of ways.
Proteins may:
• Facilitate the distribution of drugs.
• Inactivate the drug by not allowing sufficient concentration of free drug to
develop at the receptor site.
• Retard the excretion of a drug.
• Also cause displacement of body hormones or a co-administered agent.
• The structurally altered form of protein is capable of binding with a co- administered
drug.
• Drug protein complex is biologically active.
Kinetics of protein binding
The interaction between a group or free protein (P) and Drug (D) is written as,
The equilibrium constant is
Where, (PD) = Concentration of drug protein complex
(P) = concentration of unbounded protein
(D)= Total concentration of free acid
K = Association constant
........................ (2)
Substituting equation (2) in (1)
……………..…. (3)
Let r be the number of moles of drug bound, (PD), per mole of total protein, (Pt);
Then
Therefore,
The ratio r can also be expressed by converting to a linear form, convenient for plotting, by inverting it.
If ν independent binding sites are available, the expression for r, is simply ν times that for a site,
Alternative way to write this equation is to rearrange it first,
This is known as scatchard plot.

More Related Content

PPTX
SOLUBILITY OF GAS IN LIQUIDS
PPTX
Surface and Interfacial tension [Part-5] (HLB System, Solubilization )
PPT
Solubility 6 solubility of liquid in liquid & Raoult's Law
PPTX
Solubility of liquds in liquids
PPTX
PHARMACEUTICAL MICROBIOLOGY (BP303T) Unit-III Part-1 Study of morphology, cla...
PPTX
Buffers in pharmaceutical and biological system
PPTX
Complexation and Protein Binding [Part-1] (Introduction and Classification an...
PPTX
Surface and Interfacial tension [Part-6] ( Solubilization, Detergency, Adsorp...
SOLUBILITY OF GAS IN LIQUIDS
Surface and Interfacial tension [Part-5] (HLB System, Solubilization )
Solubility 6 solubility of liquid in liquid & Raoult's Law
Solubility of liquds in liquids
PHARMACEUTICAL MICROBIOLOGY (BP303T) Unit-III Part-1 Study of morphology, cla...
Buffers in pharmaceutical and biological system
Complexation and Protein Binding [Part-1] (Introduction and Classification an...
Surface and Interfacial tension [Part-6] ( Solubilization, Detergency, Adsorp...

What's hot (20)

PDF
Thixotropy pharmaceutical physical chemistry.pdf
PDF
Introduction of solubilty, solubility expression, solute solvent interaction.pdf
PPTX
State of matter and properties of matter (Part-6)(Relative humidity, Liquid ...
PPTX
Raw material and nutrition
PPTX
State of matter and properties of matter (Part-10) (Physicochemical properti...
PDF
Buffered isotonic solutions
PDF
MIXING pharmaceutical engineering 3rd sem.pdf
PPTX
Reaction of cyclopropane
PPTX
Study of principle, procedure, merits, demerits and applications of physical,...
PPTX
Surface and Interfacial tension [Part-4] (Adsorption at liquid interface, Sur...
PDF
spreading coeficient.pdf
PDF
Ph, buffers & isotonic solution
PPTX
State of matter and properties of matter (Part-3) (Eutectic mixture)
PPTX
Complexation and Protein Binding [Part-2] (Method of analysis, Complexation a...
PPTX
Unit 2 states of matter
PDF
Surface and interfacial phenomenon
PPTX
Pp unit 2
PPTX
UNIT 5TH - pH, buffers and Isotonic solutions
PPTX
Surface and Interfacial tension [Part-3(b)] (Measurement of Surface and Inter...
Thixotropy pharmaceutical physical chemistry.pdf
Introduction of solubilty, solubility expression, solute solvent interaction.pdf
State of matter and properties of matter (Part-6)(Relative humidity, Liquid ...
Raw material and nutrition
State of matter and properties of matter (Part-10) (Physicochemical properti...
Buffered isotonic solutions
MIXING pharmaceutical engineering 3rd sem.pdf
Reaction of cyclopropane
Study of principle, procedure, merits, demerits and applications of physical,...
Surface and Interfacial tension [Part-4] (Adsorption at liquid interface, Sur...
spreading coeficient.pdf
Ph, buffers & isotonic solution
State of matter and properties of matter (Part-3) (Eutectic mixture)
Complexation and Protein Binding [Part-2] (Method of analysis, Complexation a...
Unit 2 states of matter
Surface and interfacial phenomenon
Pp unit 2
UNIT 5TH - pH, buffers and Isotonic solutions
Surface and Interfacial tension [Part-3(b)] (Measurement of Surface and Inter...
Ad

Similar to Complexation 3 (20)

PDF
Complexation and protein binding
PDF
Complexation and protein binding
PPTX
Methods of analysis .nilhhhhhhhhhhh
PDF
COMPLEXATION AND PROTEIN BINDING. B.pharm
PPTX
erma.pptx
PPTX
PHYSICAL PHARMACEUTICS : COMPLEXATION AND PROTEIN BINDING.pptx
PPTX
Complexation and protein binding
PDF
Complexation and protein binding .pdf
PPTX
Complexation and protein binding
PPTX
method of analysis and protein binding.pptx
PPT
Complexation MMCP.MMDU.ppt
PPTX
Pharmaceutical Complexation and Protein Binding
PDF
Complexation & protein binding
PPTX
Complexation and plasma proteing pptinding
PPTX
COMPLEXATION AND PROTEIN BINDING
PPTX
Physicochemical Properties of Drug
PPTX
Physicochemical Properties of Drug
PPTX
Physicochemical parameters in relation to Biological activities
PPTX
Physiochemical properties
PPT
Complexation and protein binding
Complexation and protein binding
Complexation and protein binding
Methods of analysis .nilhhhhhhhhhhh
COMPLEXATION AND PROTEIN BINDING. B.pharm
erma.pptx
PHYSICAL PHARMACEUTICS : COMPLEXATION AND PROTEIN BINDING.pptx
Complexation and protein binding
Complexation and protein binding .pdf
Complexation and protein binding
method of analysis and protein binding.pptx
Complexation MMCP.MMDU.ppt
Pharmaceutical Complexation and Protein Binding
Complexation & protein binding
Complexation and plasma proteing pptinding
COMPLEXATION AND PROTEIN BINDING
Physicochemical Properties of Drug
Physicochemical Properties of Drug
Physicochemical parameters in relation to Biological activities
Physiochemical properties
Complexation and protein binding
Ad

More from Swati Gaikwad (9)

PDF
Extraction of Alkaloids by acid base shakeout
PDF
COPYRIGHT Gastro-retentive drug delivery system.pdf
PDF
Microencapsulation Technologies IN NDDS.
PDF
CONTROLLED RELEASE DRUG DELIVERY SYSTEM I
PPT
19 Fermentor.ppt
PPTX
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
PDF
Complexation 2
PDF
Complexation 1
PDF
Colloids 1
Extraction of Alkaloids by acid base shakeout
COPYRIGHT Gastro-retentive drug delivery system.pdf
Microencapsulation Technologies IN NDDS.
CONTROLLED RELEASE DRUG DELIVERY SYSTEM I
19 Fermentor.ppt
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
Complexation 2
Complexation 1
Colloids 1

Recently uploaded (20)

PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PDF
Human Health And Disease hggyutgghg .pdf
PPTX
Neuropathic pain.ppt treatment managment
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPTX
ACID BASE management, base deficit correction
PPTX
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
PPTX
CME 2 Acute Chest Pain preentation for education
PPTX
Respiratory drugs, drugs acting on the respi system
PPTX
Acid Base Disorders educational power point.pptx
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
PPTX
LUNG ABSCESS - respiratory medicine - ppt
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPTX
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
PDF
شيت_عطا_0000000000000000000000000000.pdf
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
CHEM421 - Biochemistry (Chapter 1 - Introduction)
Human Health And Disease hggyutgghg .pdf
Neuropathic pain.ppt treatment managment
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
ACID BASE management, base deficit correction
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
CME 2 Acute Chest Pain preentation for education
Respiratory drugs, drugs acting on the respi system
Acid Base Disorders educational power point.pptx
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
LUNG ABSCESS - respiratory medicine - ppt
OPIOID ANALGESICS AND THEIR IMPLICATIONS
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
شيت_عطا_0000000000000000000000000000.pdf

Complexation 3

  • 1. UNIT IV COMPLEXATION AND PROTEIN BINDING By: Ms. Swati Gaikwad Assistant Professor Nagpur Pharmacy College ,wanadongri.Nagpur
  • 2. METHODS OF ANALYSIS In the study and application of complex compounds, determination of stoichiometric ratio and stability constant is very important. 1. The stoichiometric ratio of ligand-to-metal or donor-to-acceptor. 2. Stability constant of the complex. The general methods and procedure for obtaining these quantity is as follows. 1. Method of continuous variation 2. pH titration method 3. Distribution method 4. Solubility method
  • 3. 1. Method of continuous variation • For the measurement of complexation, additive properties such as spectrophotometric extinction coefficient (absorbance), dielectric constant, refractive index etc are used. • If solutions of two species A and B are are mixed & they have no interaction or complexation, then value of property is additive and linear relationship is observed. • If Complexation occurs, the value of additive property will pass through maximum or minimum. • As shown in the figure, dielectric constant is plotted against mole fraction, and a dashed line shows that no complexation occurs and there is a linear relationship, • whereas the break or change in slope in the upper curve indicates formation of complex. • Mole fraction corresponding to the change in slope i.e. 0.5 indicates stoichiometric ratio or 1:1 complex type.
  • 4. • When spectrophotometric absorbance is used, observed values at various mole fractions is subtracted from the corresponding values that would have been expected from results of no complex. • The difference D is then plotted against the mole fraction, and from the curve fig ,molar ratio of complex is obtained. • And stability constant can be determined by means of a calculation involving concentration and absorbance difference.
  • 5. Property such as absorbance is proportional to the concentration of complex M An, hence molar ratio of ligand A and metal M and stability constant can be determined The equation for complexation can be written as And the stability constant can be written as Or in logarithmic form, Where, k = equilibrium stability constant [M] = concentration of metal ion uncomplexed [A] = concentration of ligand (A) uncomplexed n = Number of moles of ligand combined with one mole of metal ion [MAn] = concentration of complex
  • 6. 2. pH titration method • Whenever complexation is accompanied by the change in pH, pH titration method can be used. • It is the most reliable method to be used. • For example, complexation between the cupric ion and Glycine, when Glycine is added to the solution containing the cupric ions, it reacts with cupric ions and release two proton, which decreases the pH of the solution. • The potentiometric titrations are carried out and titration curves are plotted between the pH and equivalents of base added to the solution. • The figure shows that curve obtained with Glycine alone is well above and there is not much change in pH, while the curve for metal Glycine mixture indicates pH is decreased means that the complexation is occurring. • The horizontal distance between the two curves gives the amount of alkali consumed in the reaction, and this quantity is exactly equal to the concentration of ligand bound at that pH.
  • 7. Titration curves of cupric-glycine complex, and glycine. the difference in pH for a given quantity of NaoH indicates formation of complex
  • 10. Solubility method  This method exploits the change in solubility profile as a criterion to analyze the complexation.  Whenever the complexation is produced between the two components, there is inhibition or enhancement in the solubility of one of the component.  According to the solubility method, in different well stoppered containers solution of complexing agent is placed with excess quantities of drug.  These containers agitated in constant temperature bath until equilibrium is attained and supernatant liquid are removed and analyzed.  For example, complexation between p-amino benzoic acid and caffeine.
  • 11.  It is shown in the figure 5.16; the point A crossing the vertical axis indicates the solubility of drug in water.  As there is addition of caffeine, there is increase in the solubility of PABA linearly due to complexation.  As it reaches point B, there is saturation in the solution and it cannot solubilize drug anymore.  Further, increase in caffeine concentration, there is formation of complex and precipitate.  At point C all excess PABA passed into the solution and has been converted to complex.  But some uncomplexed molecules of PABA combine further with caffeine and form higher complex such as PABA 2- caffeine.
  • 12. PROTEIN BINDING Proteins in the body can bind to the drug and can influence drug action in number of ways. Proteins may: • Facilitate the distribution of drugs. • Inactivate the drug by not allowing sufficient concentration of free drug to develop at the receptor site. • Retard the excretion of a drug. • Also cause displacement of body hormones or a co-administered agent. • The structurally altered form of protein is capable of binding with a co- administered drug. • Drug protein complex is biologically active.
  • 13. Kinetics of protein binding The interaction between a group or free protein (P) and Drug (D) is written as, The equilibrium constant is Where, (PD) = Concentration of drug protein complex (P) = concentration of unbounded protein (D)= Total concentration of free acid K = Association constant ........................ (2)
  • 14. Substituting equation (2) in (1) ……………..…. (3) Let r be the number of moles of drug bound, (PD), per mole of total protein, (Pt); Then Therefore, The ratio r can also be expressed by converting to a linear form, convenient for plotting, by inverting it.
  • 15. If ν independent binding sites are available, the expression for r, is simply ν times that for a site, Alternative way to write this equation is to rearrange it first, This is known as scatchard plot.